Related by context. Frequent words. (Click for all words.) 72 metastatic hormone refractory 71 HER2 positive metastatic breast 69 metastatic renal cell carcinoma 68 malignant pleural mesothelioma 67 heavily pretreated 67 HRPC 67 relapsed refractory multiple myeloma 67 IV melanoma 67 axitinib 67 relapsed multiple myeloma 66 Jevtana 66 registrational trial 66 indolent NHL 66 hormone refractory prostate cancer 66 pertuzumab 66 non squamous 66 cabazitaxel 66 Amrubicin 65 elotuzumab 65 lymphoma CTCL 65 glufosfamide 65 gastrointestinal stromal tumors 64 glioblastoma multiforme GBM 64 lupus nephritis 64 advanced NSCLC 64 hepatitis C HCV 64 androgen independent 64 plus gemcitabine 63 Taxotere ® 63 Pivotal Phase III 63 myelodysplastic syndrome MDS 63 Alemtuzumab 63 metastatic colorectal cancer 63 adecatumumab 63 pazopanib 63 HER2 + 63 Torisel 63 mCRC 63 NSCLC 63 cutaneous T cell 62 temsirolimus 62 B CLL 62 patients evaluable 62 chronic lymphocytic leukemia CLL 62 tanespimycin 62 HGS ETR1 62 Acute Myeloid Leukemia AML 62 tumor lysis syndrome 62 medullary thyroid cancer 62 Pivotal Phase 62 aflibercept 62 deforolimus 62 abiraterone acetate 62 EGFR expressing metastatic colorectal 62 refractory multiple myeloma 62 figitumumab 62 Fludara 62 CR# vcMMAE 62 ponatinib 62 plus prednisone 61 follicular non 61 mTOR inhibitor 61 pancreatic NET 61 myelofibrosis 61 vandetanib 61 chemoradiotherapy 61 HER2 positive 61 unresectable 61 Asentar 61 abiraterone 61 TREANDA 61 sapacitabine 61 Clevudine 61 superficial bladder cancer 61 dasatinib 61 resistant ovarian cancer 61 Nexavar ® 61 TORISEL 61 Irinotecan 61 plus dexamethasone 61 Arch Intern Med 61 decitabine 61 HER2 positive breast cancer 61 castration resistant prostate cancer 61 Treanda 61 metastatic liver 61 tesetaxel 61 Phase Ib clinical 61 talactoferrin 60 Virulizin R 60 neoadjuvant therapy 60 myelodysplastic syndromes 60 Pirfenidone 60 acute myelogenous leukemia AML 60 Chronic Lymphocytic Leukemia 60 IMGN# 60 chronic HCV 60 diabetic neuropathic pain 60 L MTP PE 60 HER2 negative 60 nilotinib